Jerrold Duane Dotson is CFO & VP +1 at VistaGen Therapeutics, Inc. (VTGN). They have made 1 open-market trade across 1 company since 2021, most recently 2023-06-30.
CIK 0001388853
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VTGN | 3,671 | $740 |
Shares reported on the most recent Form 4, priced at the 2023-07-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VTGN | SELL | 2021-09-07 | 2021-09-08 | $3.13 | $94K | -10.0% | -19.0% | -42.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.